2026 CureSearch PEDS
The 2026 CureSearch PEDS meeting will be taking a different format this year. We’ve thoughtfully reimagined the format into a dynamic, four-part webinar series designed to foster deeper, more strategic dialogue across research, regulatory, clinical, and industry leaders. Most notably, the series will now be free and open to the public, which will significantly expand reach and engagement across the pediatric oncology community.
This refreshed format creates meaningful visibility and thought-leadership alignment while bringing the larger community into the conversation around pediatric cancer drug development.
You can easily register for FREE at our website here: https://
April | The Starting Point
April 23 | 12:00 PM ET
April 23 | 12:00 PM ET
Speakers: Beth Fox, MD – Senior Vice President, Clinical Trials Research, St. Jude; Nicole Drezner, MD – Deputy Director, Division of Oncology 2, FDA; Michael Cox, PharmD – Senior Vice President, Head of Early Development, Circle Pharma
June | Capital, Risk, and Strategy: Rethinking How Pediatric Cancer Drug Development is Funded to Move Therapies Forward
June 16 | 12:00-1:30pm ET
Speakers: Michele Cleary, PhD, Chief Executive Officer, Advancium Health Network; Andrew Lo, PhD, Charles E. and Susan T. Harris Professor, MIT Sloan School of Management; Wendy Jacquemet-Ross, PhD, CLP, Head of Partnerships, Childhood Cancer, LifeArc; Stacey Adam, PhD, Vice President, Science Partnerships, Foundation for the National Institutes of Health (FNIH)
September | From Lab to Clinic: Turning Pediatric Cancer Research into Real Treatments for Children
September 21 | 12:30-2:00pm ET
Speakers: Crystal Mackall, MD, Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and Medicine, Stanford University; Ranjit S. Bindra, MD, PhD, Harvey and Kate Cushing Professor of Therapeutic Radiology and Professor of Pathology, Yale University; Gregory K. Friedman, MD, Professor, Department of Pediatrics Patient Care and Mosbacher Pediatrics Chair and Section Chief, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
Moderator: Brenda Weigel, MD (Moderator), Vice President, Clinical Research Industry Engagement, St. Jude Children’s Research Hospital
November | What Comes Next
Speakers / Date TBA
